Also, 16.7% of gastric adenocarcinomas and 15% of pancreatic adenocarcinomas showed a CK7+ CK20+ immunoprofile, and 78.8% of colon adenocarcinomas were found to be CK7- CK20+. This evidence concerns the gene KRT7 and gastric adenocarcinoma.